FDA 483 OBSERVATION · #5 OF 1,923 MOST-CITED
Personnel
FDA cited this observation 1,665 times across 1,465 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this grouping is not
An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.
What this observation means, and how to comply
SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.
Personnel were not qualified, trained, or supervised adequately for the tasks they performed, or personal hygiene and disease-control practices were insufficient to prevent contamination of product.
Why FDA writes it — People execute every control the quality system defines. Untrained or unsupervised personnel — or poor hygiene in a food operation — is a direct route to contamination and error, which is why FDA cites the human element as a first-order finding.
- Ensure personnel have the education, training, and experience — or a combination — to perform their assigned functions, and document that qualification.
- Train personnel in the particular operations they perform and in the principles of hygiene and food or drug safety relevant to their role, on a continuing basis.
- Enforce hygiene and disease-control practices — hand washing, protective clothing, exclusion of ill personnel from food-contact work — where contamination is a risk.
- Provide supervision sufficient to ensure procedures are actually followed, and keep training records current.
- Training recorded as a one-time onboarding event and never refreshed as procedures or roles change.
- Qualification asserted but undocumented, so there is no evidence the operator was competent for the task.
How to close this finding — and stop it recurring
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1× the rate of the average FDA-cited firm (7.4% vs 7.8%), across 1,465 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
You did not take a reasonable measure or precaution related to personnel practices.
You did not take a reasonable measure or precaution related to personnel practices.
You did not take a reasonable measure or precaution related to personnel practices.
You did not take a reasonable measure or precaution related to personnel practices.
You did not take a reasonable measure or precaution related to personnel practices.
You did not take a reasonable measure or precaution related to personnel practices.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →